Agios Pharmaceuticals
AGIO
#4595
Rank
โ‚ฌ1.50 B
Marketcap
26,24ย โ‚ฌ
Share price
3.80%
Change (1 day)
-1.43%
Change (1 year)

EPS for Agios Pharmaceuticals (AGIO)

EPS in 2023 (TTM): -3,66ย โ‚ฌ

According to Agios Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -3,65ย โ‚ฌ. In 2022 the company made an earnings per share (EPS) of -3,91ย โ‚ฌ a decrease over its 2021 EPS that were of 20,52ย โ‚ฌ.

EPS history for Agios Pharmaceuticals from 2012 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-3,66ย โ‚ฌ-6.41%
2022-3,91ย โ‚ฌ-119.06%
202120,52ย โ‚ฌ-569.2%
2020-4,37ย โ‚ฌ-31%
2019-6,34ย โ‚ฌ13.93%
2018-5,56ย โ‚ฌ-10.53%
2017-6,22ย โ‚ฌ33.47%
2016-4,66ย โ‚ฌ61.34%
2015-2,89ย โ‚ฌ98.1%
2014-1,46ย โ‚ฌ-4.34%
2013-1,52ย โ‚ฌ12.03%
2012-1,36ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-1,97ย โ‚ฌ-45.82%๐Ÿ‡บ๐Ÿ‡ธ USA
0,26ย โ‚ฌ-107.17%๐Ÿ‡บ๐Ÿ‡ธ USA
1,72ย โ‚ฌ-147.09%๐Ÿ‡บ๐Ÿ‡ธ USA
0,72ย โ‚ฌ-119.71%๐Ÿ‡บ๐Ÿ‡ธ USA
3,23ย โ‚ฌ-188.63%๐Ÿ‡ฌ๐Ÿ‡ง UK
5,01ย โ‚ฌ-237.45%๐Ÿ‡บ๐Ÿ‡ธ USA